Residential proximity to a fertility clinic is independently associated with likelihood of women having ART and IUI treatment.
Australia
assisted reproductive technology
geographic accessibility
intrauterine insemination
medically assisted fertility treatments
social inequalities
utilization
Journal
Human reproduction (Oxford, England)
ISSN: 1460-2350
Titre abrégé: Hum Reprod
Pays: England
ID NLM: 8701199
Informations de publication
Date de publication:
31 10 2022
31 10 2022
Historique:
received:
13
04
2022
revised:
31
08
2022
pubmed:
17
9
2022
medline:
4
11
2022
entrez:
16
9
2022
Statut:
ppublish
Résumé
Is geographic proximity to a fertility clinic associated with the likelihood of women of reproductive age undertaking different forms of medically assisted fertility treatment? After adjusting for socioeconomic status (SES) and other confounders including a proxy for the need for infertility treatment, women who lived within 15 km of a fertility clinic were 21% more likely to undergo ART treatment and 68% more likely to undergo IUI treatment than those who lived further than 60 km away. In most countries, patients living outside of metropolitan areas are more likely to be more socio-economically disadvantaged and to have less equitable access to healthcare. However, how a woman's residential proximity to fertility clinics predicts utilization of high-cost/high-technology treatment (ART) and low-cost/low-technology treatment (IUI) is limited, and whether socio-economic disadvantage explains much of the hypothesized lower utilization is unknown. Australia's universal insurance scheme provides supportive reimbursement for almost all ART and IUI treatment regardless of age or number of cycles, providing a unique setting to investigate disparities in access to infertility treatment. National population-based observation study of ART and IUI treatment utilization by women across socio-economic gradients and Australian residential locations between August 2015 and December 2017. Universal insurance claims information on female patients who underwent ART or IUI were provided by Services Australia, comprising 67 670 female patients who accessed 162 795 ART treatments, and 10 211 female patients who accessed 19 615 IUI treatments over a 29-month period. Incidence rates by SES and proximity to fertility clinics were calculated to describe the number of women undergoing at least one ART or IUI treatment cycle per 1000 women of reproductive age (25-44). Treatment frequencies were calculated to describe the average number of ART or IUI treatment cycles per woman of reproductive age who had undergone at least one ART or IUI treatment during the study period. Poisson regression analyses were used to estimate the independent effect on accessibility to infertility treatment by geographic proximity (based on small area locations) to the closest fertility clinic after adjusting for SES, childbearing delay, remoteness area, and marital status. On average, 19.1 women per 1000 women of reproductive age underwent at least one fresh or frozen ART cycle, with an average 2.3 ART cycles each, while 3.0 women per 1000 women of reproductive age received at least one IUI cycle, with an average of 1.6 IUI cycles each. After adjusting for SES and other confounders including a proxy for the need for infertility treatment, women who lived within 15 km of a fertility clinic were 21% more likely to undergo ART treatment and 68% more likely to undergo IUI than those who lived over 60 km away. Regardless of geographic location, there was a steady and independent gradient in access to ART treatment based on increasing SES, with women residing in the most advantaged residential quartile having a 37% higher rate of receiving ART treatment compared to those in the most disadvantaged quartile. The negative effect of social disadvantage on ART use became more pronounced as distance from a fertility clinic grew, indicating that the barriers to access to ART care caused by distance were further compounded by the level of socioeconomic advantage of the women's residential location. In contrast, socioeconomic status did not modify the likelihood of using IUI over and above the distance from a fertility clinic. In relation to IUI treatment, differences in utilization by SES disappeared after adjusting for geographic proximity to a fertility clinic, childbearing delay, remoteness area, and marital status. Information is aggregated by small geographic areas and it therefore may not reflect individual characteristics. Australia provides partial but comparably supportive reimbursement for both ART and IUI through its universal healthcare system and thus the results may not be fully generalizable to other settings. Residential proximity to a fertility clinic is a persistent barrier to accessing ART and IUI treatment, regardless of SES, even in countries characterized by supportive public funding, such as Australia. SES is less of a barrier to accessing IUI than ART, presumably driven by the lower cost and fewer clinic visits required with IUI treatment. Safe and effective fertility treatment should be available to all women regardless of where they live. This work was supported by the Australian National University Research scholarship and by the Higher Degree Research Fee Merit Scholarship. The authors have no conflict of interest. N/A.
Identifiants
pubmed: 36112009
pii: 6702085
doi: 10.1093/humrep/deac205
pmc: PMC9627258
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2662-2671Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology.
Références
Hum Fertil (Camb). 2017 Jun;20(2):88-95
pubmed: 27778517
Hum Reprod. 2021 Oct 18;36(11):2921-2934
pubmed: 34601605
PLoS One. 2017 Aug 10;12(8):e0180698
pubmed: 28797037
Hum Reprod Open. 2020 Jul 31;2020(3):hoaa032
pubmed: 32760812
Hum Reprod. 2019 Nov 1;34(11):2173-2183
pubmed: 31725877
Hum Reprod Update. 2015 Jul-Aug;21(4):411-26
pubmed: 25801630
Longit Life Course Stud. 2021 Apr 01;13(2):307-334
pubmed: 35920646
Hum Reprod. 2013 Feb;28(2):385-97
pubmed: 23184181
Hum Reprod. 2008 Sep;23(9):2050-5
pubmed: 18544578
Hum Reprod. 2017 Nov 1;32(11):2305-2314
pubmed: 29040579
Fertil Steril. 2009 Jun;91(6):2281-94
pubmed: 19481642
Health Policy. 2008 Apr;86(1):97-108
pubmed: 18006176
Gynecol Obstet Invest. 2009;68(1):58-64
pubmed: 19401627
Fertil Steril. 2016 Jun;105(6):1584-1588.e1
pubmed: 26953733
Fertil Steril. 2004 Feb;81(2):258-61
pubmed: 14967352
Fertil Steril. 2011 Jul;96(1):95-101
pubmed: 21616487
Geospat Health. 2015 Nov 04;10(2):358
pubmed: 26618314
Hum Reprod. 2020 Jun 1;35(6):1441-1450
pubmed: 32463875
Reprod Biomed Soc Online. 2020 May 13;10:46-57
pubmed: 32760816
Hum Reprod. 2013 Nov;28(11):3111-7
pubmed: 23906901
Health Care Financ Rev. 2000 Summer;21(4):23-43
pubmed: 11481743
Public Health. 2012 Sep;126 Suppl 1:S4-S10
pubmed: 22784581
Hum Reprod. 2011 Mar;26(3):584-93
pubmed: 21227936
Reprod Biomed Online. 2016 Nov;33(5):575-584
pubmed: 27595434